Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks ...

DexCom recently reported preliminary fourth-quarter results showing year-over-year revenue growth in both U.S. and ...

DexCom reported strong preliminary Q4 results, with topline figures above its earlier expectations. The company paired this ...

New CEO of Dexcom, Jake Leach, joined MobiHealthNews at the JPM Healthcare Conference to discuss his leadership priorities, CGM access and the role of wearables in preventive care.

If you are wondering whether DexCom's current share price really reflects what you are getting for your money, you are not alone. The stock last closed at US$73.67, with returns of 4.2% over 7 days, 9 ...

Your device's unique device identifier and model number are on the back of your receiver. Some of Dexcom's continuous glucose monitoring receivers have been recalled due to speaker malfunctions, which ...

DexCom treats about 2.5 million patients, with tons of room for more. The company's Q2 guidance bombshell tanked the stock. Competition from an unexpected source raises long-term concerns worth ...

Ed Gamble and Roxy Horner, who live with Type 1 diabetes, at the Dexcom's "No Pricks Parlour" vintage ice cream truck, handing out free ice cream on London's South Bank to celebrate Diabetes Awareness ...

It has had strong momentum since November, but there is still plenty of upside left.